Skip to content
cccskills
FreePublished on GitHub

es-cushing-suggest-rt-radiosurgery-failed-tss-recurrent-cd

This skill suggests radiation therapy or radiosurgery for adult patients with Cushing's disease who have failed transsphenoidal surgery (TSS) or have recurrent disease after initial remission. Consider when postoperative urinary free cortisol or late-night salivary cortisol remains elevated, or when clinical recurrence is suspected.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.5 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Suggest Radiation Therapy/Radiosurgery for Patients Who Have Failed Transsphenoidal Surgery or Have Recurrent Cushing's Disease

STEP 1 — Gather Information

Collect postoperative urinary free cortisol (UFC), late-night salivary cortisol, serum cortisol, pituitary MRI, and symptom review; document timing since TSS.
If any test is abnormal and >6 weeks post‑TSS, proceed to Step 2.

STEP 2 — Rule In / Rule Out

Determine whether hypercortisolism is persistent/recurrent vs transient early postoperative stress: elevated UFC or late-night salivary cortisol off medication beyond the immediate postoperative period indicates persistent/recurrent disease.
If persistent/recurrent hypercortisolism is confirmed, proceed to Step 3; otherwise repeat testing in 4–6 weeks.

STEP 3 — Classify or Stratify

Classify as persistent disease (never achieved remission) or recurrent disease (initial remission then loss of remission); both warrant second‑line RT/RS consideration.
Proceed to Step 4 for either classification.

STEP 4 — Decide

Refer for radiation therapy or radiosurgery after confirming that medical therapy can normalize cortisol pre‑radiation (per guideline 6.3); obtain baseline pituitary MRI and endocrine evaluation.
Initiate RT/RS planning and schedule postoperative cortisol monitoring at 6‑ to 12‑month intervals.

Clinical Guardrails / Mimics / Pitfalls

Do not irradiate without demonstrable biochemical control of cortisol by medical therapy; avoid RT in uncontrolled hyperglycemia or active psychosis; monitor for hypopituitarism and optic neuropathy post‑RT; consider pregnancy contraindication.

Concrete Clinical Example

A 34‑year‑old woman with Cushing’s disease underwent TSS; postoperative UFC remained 2× ULN at 8 weeks and late‑night salivary cortisol was elevated. She failed ketoconazole due to liver toxicity. She was referred for stereotactic radiosurgery; at 6‑month follow‑up UFC normalized and symptoms resolved.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI: 10.1210/jc.2015-1818

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill